Debt-to-equity of SOLENO THERAPEUTICS INC from 30 Sep 2015 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
SOLENO THERAPEUTICS INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 31 Dec 2025.
  • SOLENO THERAPEUTICS INC Debt-to-equity for the quarter ending 31 Dec 2025 was 28%, a 57% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

SOLENO THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 28% +10% +57% 31 Dec 2025
Q3 2025 30% +18% +148% 30 Sep 2025
Q2 2025 30% +12% +62% 30 Jun 2025
Q1 2025 22% -9.7% -30% 31 Mar 2025
Q4 2024 18% -33% -65% 31 Dec 2024
Q3 2024 12% -177% -93% 30 Sep 2024
Q2 2024 19% -150% -89% 30 Jun 2024
Q1 2024 32% -105% -77% 31 Mar 2024
Q4 2023 51% -40% -44% 31 Dec 2023
Q3 2023 189% +105% +124% 30 Sep 2023
Q2 2023 168% +82% +96% 30 Jun 2023
Q1 2023 137% +52% +62% 31 Mar 2023
Q4 2022 91% +12% +16% 31 Dec 2022
Q3 2022 84% +21% +34% 30 Sep 2022
Q2 2022 86% +33% +63% 30 Jun 2022
Q1 2022 84% +39% +86% 31 Mar 2022
Q4 2021 78% +23% +41% 31 Dec 2021
Q3 2021 63% -8.9% -12% 30 Sep 2021
Q2 2021 53% -33% -39% 30 Jun 2021
Q1 2021 45% -105% -70% 31 Mar 2021
Q4 2020 56% -52% -48% 31 Dec 2020
Q3 2020 72% -3.2% -4.3% 30 Sep 2020
Q2 2020 86% +7.2% +9.1% 30 Jun 2020
Q1 2020 150% +78% +108% 31 Mar 2020
Q4 2019 108% +38% +54% 31 Dec 2019
Q3 2019 75% +2.6% +3.6% 30 Sep 2019
Q2 2019 79% +29% +57% 30 Jun 2019
Q1 2019 72% +40% +125% 31 Mar 2019
Q4 2018 70% +49% +228% 31 Dec 2018
Q3 2018 72% +57% +375% 30 Sep 2018
Q2 2018 50% 30 Jun 2018
Q1 2018 32% 31 Mar 2018
Q4 2017 21% 31 Dec 2017
Q3 2017 15% 30 Sep 2017
Q4 2015 -302% 31 Dec 2015
Q3 2015 -210% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.